Search

Legal Cannabis production is now experiencing growing consumer demand due to changing legislation around the world. However, because of heavy restrictions on cannabis cultivation over the past century, little scientific research has been conducted on this crop, in particular around use of members of the phytomicrobiome to improve crop yields. Recent developments in the field of plant science have demonstrated that application of microbes, isolated from the rhizosphere, have enormous potential to improve yields, in particular under stressful growing conditions. This perspective carefully examines the potential for plant growth-promoting rhizobacteria (PGPR) to improve marijuana and hemp yield and quality. It then explores the potential use of PGPR for biological control of plant pathogens, which is particularly interesting given the stringent regulation of pesticide residues on this crop. As an industry-relevant example, biocontrol of powdery mildew, a common and deleterious pathogen affecting cannabis production, is assessed. Finally, two PGPR in genera frequently associated with higher plants ( Pseudomonas and Bacillus ) were selected as case studies for the potential effects on growth promotion and disease biocontrol in commercial cannabis production.

Purpose: To evaluate the efficacy of WAY-121,509, a potent new aldose reductase inhibitor (ARI), in preventing the retinopathy that develops in the galactose-fed rat model of diabetic ocular complications., Methods: Sprague-Dawley rats were randomized into treatment and duration groups and fed diets with either 50% starch of 50% galactose with or without WAY-121,509 (25 mg/kg body weight per day). Progression of cataracts was monitored by slit-lamp biomicroscopy. After duration of 4, 8, 16, and 24 months, levels of plasma glucose and glycated hemoglobin, as well as erythrocyte and retinal galactose and galactitol, were measured in rats in each group. Retinal vasculatures of the 24-month rats were isolated by elastase digestion and analyzed by computer-assisted morphometry., Results: Mature, diabetic-like cataracts developed within 5 weeks in all the galactose-fed, untreated rats, but only nonprogressive anterior cortical opacities were present in lenses of 85% of the ARI-treated galactosemic animals after 3 months. Plasma glucose remained the same in all groups. Erythrocyte and retinal galactose and glycated (galactosylated) hemoglobin were elevated with galactosemia and were unaffected by ARI treatment. Erythrocyte and retinal galactitol levels were decreased by 91% and 95%, respectively, with inhibitor treatment. At 24 months, capillary length, width, density, the number of microaneurysms, and the percent of capillary length involved in intraretinal microvascular abnormalities, expressed as hypercellular channels with diameters > 20 microns, were significantly increased by galactosemia and were attenuated in the galactose-fed, ARI-treated group., Conclusions: A dose of WAY-121,509 sufficient to reduce retinal polyol levels by 95% ameliorated the development of galactose-induced cataracts and diabetic-like retinopathy but was insufficient to prevent early lens opacifications or all the diabetic-like retinal microangiopathies.

The speckle camera in regular use at Kitt Peak National Observatory since 1974 is described in detail. The design of the atmospheric dispersion compensation prisms, the use of film as a recording medium, the accuracy of double star measurements, and the next generation speckle camera are discussed. Photographs of double star speckle patterns with separations from 1.4 sec of arc to 4.7 sec of arc are shown to illustrate the quality of image formation with this camera, the effects of seeing on the patterns, and to illustrate the isoplanatic patch of the atmosphere.